Trial intelligence / Profile preview

Venofer in Peritoneal Dialysis Patients

NCT00236938Phase 3Completed

Sponsor
American Regent, Inc.
Start
Jul 2002
Primary completion
Sep 2004
Modality
Small Molecules
01

Overview

Phase 3, randomised, open-label trial of iron sucrose in anemia (2 arms), sponsored by American Regent, Inc. Primary endpoint: Mean Change From Baseline to the Highest Hemoglobin up to Day 71. Started Jul 2002; status: completed.

02

Drugs

iron sucrose
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00236938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00236938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call